Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Payables: 2014-2025

Historic Payables for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $174.6 million.

  • Surgery Partners' Payables rose 222.48% to $174.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.6 million, marking a year-over-year increase of 222.48%. This contributed to the annual value of $208.7 million for FY2024, which is 2147.85% up from last year.
  • Per Surgery Partners' latest filing, its Payables stood at $174.6 million for Q3 2025, which was up 222.48% from $174.9 million recorded in Q2 2025.
  • Surgery Partners' Payables' 5-year high stood at $208.7 million during Q4 2024, with a 5-year trough of $96.0 million in Q1 2021.
  • Over the past 5 years, Surgery Partners' median Payables value was $148.8 million (recorded in 2023), while the average stood at $148.7 million.
  • As far as peak fluctuations go, Surgery Partners' Payables plummeted by 1011.24% in 2021, and later soared by 3231.94% in 2024.
  • Surgery Partners' Payables (Quarter) stood at $124.9 million in 2021, then rose by 21.38% to $151.6 million in 2022, then rose by 13.32% to $171.8 million in 2023, then rose by 21.48% to $208.7 million in 2024, then dropped by 16.34% to $174.6 million in 2025.
  • Its Payables was $174.6 million in Q3 2025, compared to $174.9 million in Q2 2025 and $165.0 million in Q1 2025.